Compare · GTH vs HUM
GTH vs HUM
Side-by-side comparison of Genetron Holdings Limited (GTH) and Humana Inc. (HUM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GTH and HUM operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $49.64B, about 158.2x GTH ($313.7M).
- HUM has hit the wire 13 times in the past 4 weeks while GTH has been quiet.
- HUM has more recent analyst coverage (25 ratings vs 0 for GTH).
- Company
- Genetron Holdings Limited
- Humana Inc.
- Price
- $4.02+0.00%
- $215.14+0.15%
- Market cap
- $313.7M
- $49.64B
- 1M return
- -
- +23.51%
- 1Y return
- -
- -18.25%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- News (4w)
- 0
- 13
- Recent ratings
- 0
- 25
Genetron Holdings Limited
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early liver cancer screening services through laboratory developed tests services, such as HCCscreen, a proprietary assay for the early screening of hepatocellular carcinoma. It also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product based on semiconductor sequencing to detect lung cancer; Genetron 3D biochip reading instrument; IDH1 and TERT gene assays for glioma; Genetron S5 platform, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; and Genetron S2000 platform, a production-scale sequencer. In addition, the company develops ctDNA lung cancer assay for mutations in the epidermal growth factor receptor gene. Further, it offers development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies, hospitals, and research institutions worldwide. The company has a strategic partnership with JD Health to create solutions for full-cycle cancer management. Genetron Holdings Limited was founded in 2015 and is headquartered in Beijing, the People's Republic of China.
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Latest GTH
- SEC Form 15-12G filed by Genetron Holdings Limited
- SEC Form SC 13D/A filed by Genetron Holdings Limited (Amendment)
- SEC Form SC 13D/A filed by Genetron Holdings Limited (Amendment)
- SEC Form SC 13D/A filed by Genetron Holdings Limited (Amendment)
- SEC Form SC 13D/A filed by Genetron Holdings Limited (Amendment)
- SEC Form S-8 POS filed by Genetron Holdings Limited
- SEC Form 25-NSE filed by Genetron Holdings Limited
- SEC Form SC 13E3/A filed by Genetron Holdings Limited (Amendment)
- Genetron Health Announces Completion of Going Private Transaction
- SEC Form 6-K filed by Genetron Holdings Limited
Latest HUM
- SEC Form 3 filed by new insider Field Robert Stuart
- Humana Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- CenterWell Introduces the Fulfillment Index, a New Measure of What It Means to Age Well
- SEC Form S-8 filed by Humana Inc.
- Humana Board Declares Payment of Quarterly Dividend to Stockholders
- On the Line for Lung Health: Telephone Training Helps COPD Patients Perfect Inhaler Use
- Tuesday Health Expands National Footprint With Humana Partnership to Advance Value-Based Palliative Care
- Humana Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Humana Elects Robert S. Field to Board of Directors
- Humana Goes Live with b.well to Deliver on Health Data Interoperability Commitments